Chitosan delivery systems for the treatment of oral mucositis: In vitro and in vivo studies

Journal of Controlled Release

Volumn 98, Issue 2, 2004, Pages 269-279

  Aksungur, Pelin ^a   Sungur, Arzu ^a   Ünal, Serhat ^a   Iskit, Alper B ^a   Squier, Christopher A ^b   Şenel, Sevda ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

Chitosan; Film; Gel; In vivo studies; Nystatin; Oral mucositis

Indexed keywords

DRUG PRODUCTS; GELS; MOLECULAR WEIGHT; PATHOLOGY; RISK ASSESSMENT; TUMORS;

CHITOSAN DELIVERY SYSTEMS; ORAL MUCOSA;

CHEMOTHERAPY;

CHITOSAN DERIVATIVE; CHITOSAN H; FLUOROURACIL; NYSTATIN; PROTASAN CL 213; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANDIDA ALBICANS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG DISTRIBUTION; DRUG EFFECT; DRUG FORMULATION; DRUG RETENTION; DRUG SALIVA LEVEL; GEL; HAMSTER; HUMAN; HUMAN EXPERIMENT; MALE; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR WEIGHT; MOUTH CAVITY; MUCOSA INFLAMMATION; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SURVIVAL RATE; SUSPENSION;

ADULT; ANIMALS; ANTIFUNGAL AGENTS; BIOLOGICAL AVAILABILITY; BODY WEIGHT; CHITOSAN; CRICETINAE; CROSS-OVER STUDIES; DRUG DELIVERY SYSTEMS; DRUG THERAPY, COMBINATION; FLUOROURACIL; GELS; HISTOCYTOCHEMISTRY; HUMANS; LACTIC ACID; MALE; MESOCRICETUS; MOUTH MUCOSA; NYSTATIN; POLYPHOSPHATES; SALIVA; STOMATITIS; SURVIVAL RATE; TREATMENT OUTCOME; WATER;

EID: 3242713144     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2004.05.002     Document Type: Article

References (28)

1. Zegarelli D.J. Fungal infections of the oral cavity. Otolaryngol. Clin. North Am. 26(6):1993;1069-1089
2. Scully C., el-Kabir M., Samaranayake L.P. Candida and oral candidosis: a review. Crit. Rev. Oral Biol. Med. 5(2):1994;125-157
3. Greenspan D., Greenspan J.S. HIV-related oral disease. Lancet. 348:1996;729-733
4. Foote R.L., Loprinzi C.L., Frank A.R., O'Fallon J.R., Gulavita S., Tewfik H.H., Ryan M.A., Earle J.M., Novotny P. Randomized trial of a chlorhexidine mouthwash for alleviation of radiation-induced mucositis. J. Clin. Oncol. 12(12):1994;2630-2633
5. Banting D.W., Greenhorn P.A., McMinn J.G. Effectiveness of a topical antifungal regimen for the treatment of oral candidiasis in older, chronically ill, institutionalized, adults. J. Can. Dent. Assoc. 61(3):1995;203-205
6. Ishida M., Rambu N., Nagai T. Mucosal dosage form of lidocaine for toothache using hydroxypropyl cellulose and carbopol. Chem. Pharm. Bull. 30(3):1982;4561-4564
7. Ponchel G., Touchard F., Wouessidjewe D., Duchêne D., Peppas N.A. Bioadhesive analysis of controlled release systems: III. Bioadhesive and release behavior of metronidazole-containing poly(acrylic acid)-hydroxypropyl methylcellulose systems. Int. J. Pharm. 38:1987;65-70
8. Veillard M.M., Longer M.A., Mortens T.W., Robinson J.R. Preliminary studies of oral mucosal delivery of peptide drugs. J. Control. Release. 6:1987;123-131
9. DeVries M.E., Boddé H.E., Buscher H.J., Junginger H.E. Hydrogels for buccal drug delivery: properties relevant for mucoadhesion. J. Biomed. Mater. Res. 22:1988;1023-1032
10. Gandhi R.B., Robinson J.R. Oral cavity as a site for bioadhesive drug delivery. Adv. Drug Deliv. Rev. 13:1994;43-47
11. Şenel S., İkinci G., Kaş S., Yousefi-Rad A., Sargon M.F., Hincal A.A. Chitosan films and hydrogels of chlorhexidine gluconate for oral mucosal delivery. Int. J. Pharm. 193:2000;197-203
12. Needleman I.G., Martin G.P., Smales F.C. An investigation of bioadhesion for periodontal and mucosal drug delivery. J. Clin. Periodontol. 24:1997;394-400
13. Şenel S., Kaş H.S., Squier C.A. Application of chitosan in dental drug delivery and therapy. Muzzarelli A.A.R. Chitosan Per Os: From Dietary Supplement to Drug Carrier. 2000;241-256 Atec, Grottammare, Italy
14. Miyazaki S., Nakayama A., Oda M., Takada M., Attwood D. Chitosan and sodium alginate based bioadhesive tablets for intraoral delivery. Biol. Pharm. Bull. 17:1994;745-747
15. Knapczyk J., Macura A.B., Pawlik B. Simple tests demonstrating the antimycotic effect of chitosan. Int. J. Pharm. 80:1992;33-38
16. Şenel S., Kremer M.J., Kaş S., Wertz P.W., Hincal A.A., Squier C.A. Enhancing effect of chitosan on peptide drug delivery across buccal mucosa. Biomaterials. 21:2000;2067-2071
17. Şenel S., Kremer M.J., Wertz P.W., Hy̧ncal A.A., Squier C.A. Buccal permeation of hydrocortisone from chitosan films, 29th Int. Symp. Control. Rel. Bioact. Mater. # 579, Seoul, South Korea, 20-25 July:2002
18. Sonis S.T., Tracer C., Shklar G., Jenson J., Florine D. An animal model for mucositis induced by cancer chemotherapy. Oral Surg. Oral Med. Oral Pathol. 69(4):1990;437-443
19. Sonis S.T., Peterson R.L., Edwards L.J., Lucey C.A., Wang L., Mason L., Login G., Ymamkawa M., Moses G., Bouchard P., Hayes L.L., Bedrosian C., Dorner A.J. Defining mechanisms of action of interleukin-11 on the progression of radiation-induced oral mucositis in hamsters. Oral Oncol. 36(4):2000 (Jul.);373-381
20. Aksungur P., Şenel S., Özalp M., Hincal A.A. Formulation and in vitro evaluation of nystatin loaded chitosan microspheres for the treatment of oral candidiasis, 61st International Congress of FIP, Singapore, 1-6 September:2001
21. İkinci G., Şenel S., Akincibay H., Kaş S., Erciş S., Wilson C.G., Hincal A.A. Effect of chitosan on a periodontal pathogen, Porphyromonas gingivalis. Int. J. Pharm. 235:2002;121-127
22. Alsarra Ibrahim A., Betigeri S.S., Zhang H.U.A., Evans B.A., Neau S.H. Molecular weight and degree of deacetylation effects on lipase-loaded chitosan bead characteristics. Biomaterials. 23:2002;3637-3644
23. Genta I., Perugini P., Pavanetto F. Different molecular weight chitosan microspheres: influence on drug loading and drug release. Drug Dev. Ind. Pharm. 24:1998;779-784
24. Shiraishi S., Imai T., Otagirim M. Controlled release of indomethacin by chitosan-polelectrolyte complex: optimization and in vivo/in vitro evaluation. J. Control. Release. 25:1993;217-225
25. Risbud M.V., Hardikar A.A., Bhat B.S., Bhonde R.R. pH-sensitive freeze-dried chitosan-polyvinil pyrrolidone hydrogels as controlled release systems for antibiotic delivery. J. Control. Release. 68:2000;23-30
26. Bodmeier R., Oh K.H., Pramar Y. Preparation and evaluation of drug-containing chitosan beads. Drug Dev. Ind. Pharm. 15:1989;1475-1494
27. Shu X.Z., Zhu K.J. A novel approach to prepare tripolyphosphate/chitosan complex beads for controlled release drug delivery. Int. J. Pharm. 201:2000;51-58
28. Weatherell J.A., Robinson C., Rathbone M.J. The flow of saliva and its influence on the movement, deposition and removal of drugs administered to the oral cavity. Rathbone M.J. Oral Mucosal Delivery. 1996;157-190 Marcel Dekker, New York